Delta Variant of Covid-19 and Hearing Loss

被引:0
|
作者
Abishek Umashankar
Praveen Prakash
Prashanth Prabhu
机构
[1] All India Institute of Speech and Hearing Mysuru,Department of Audiology
[2] All India Institute of Speech and Hearing Mysuru,undefined
关键词
Delta variant; Hearing loss; Thrombosis; Cross reaction; Hearing care management;
D O I
暂无
中图分类号
学科分类号
摘要
The Coronavirus Disease of 2019 has now become one of the biggest pandemics of all time. Under the influence of ongoing mutations and widespread geographical expansions, several variants have been reported. Among those, the B.1.617.2 variant, most commonly known as the ‘Delta variant’ of the coronavirus disease – 19, was first reported in the state of Maharashtra of India in December 2020 and have currently been detected in over 43 countries across six continents around the globe. The B.1.617.2 variant of COVID 19 is a more treacherous variant than the alpha variant due to the increased replication leading to higher viral loads and increased transmission with minimal literature reporting about vaccines’ efficacy. In patients with the Alpha variant of COVID-19, hearing loss was an infrequent symptom seen, but on the other hand, the Delta variant happens to have a more frequent hearing loss as a symptom. The increased severity could be one of the reasons why hearing loss could be a typically seen symptom with high chances of occurrence of either a thrombosis, cross-reaction, labyrinthitis/neuritis, etc. and thus audiologists and otolaryngologists must be prepared for the post effect of the delta variant to evaluate and rehabilitate the individuals affected with hearing loss. The following article discusses the presence of hearing loss in individuals with delta variant of COVID 19 and the role of audiologists and otolaryngologists in hearing care.
引用
收藏
页码:2634 / 2636
页数:2
相关论文
共 50 条
  • [11] Hearing loss and COVID-19: an umbrella review
    Esmaeil Mehraeen
    Arian Afzalian
    Amir Masoud Afsahi
    Ramin Shahidi
    Amirata Fakhfouri
    Kiana Karimi
    Sanaz Varshochi
    Mohammad Amin Habibi
    Ayoob Molla
    Ali Dadjou
    Zohreh Tajabadi
    Khadijeh Nasiri
    Seyed Ahmad Seyed Alinaghi
    Daniel Hackett
    European Archives of Oto-Rhino-Laryngology, 2023, 280 : 3515 - 3528
  • [12] Lifting of COVID-19 restrictions in the UK and the Delta variant
    Burki, Talha Khan
    LANCET RESPIRATORY MEDICINE, 2021, 9 (08): : E83 - E83
  • [13] On Australia's battle with the covid-19 delta variant
    Johns, Steve
    NEW SCIENTIST, 2021, 245 (3350) : 20 - 20
  • [14] Cynomolgus Macaque Model for COVID-19 Delta Variant
    Baek, Seung Ho
    Oh, Hanseul
    Koo, Bon-Sang
    Kim, Green
    Hwang, Eun-Ha
    Jung, Hoyin
    An, You Jung
    Park, Jae-Hak
    Hong, Jung Joo
    IMMUNE NETWORK, 2022, 22 (06)
  • [15] Secondary Infections in the Setting of COVID-19 Delta Variant
    Dominguez, B.
    Magh, A.
    Jones, T. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [16] Hearing loss before and after COVID-19 pandemic
    Daimaru, Kaori
    Wagatsuma, Yukiko
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50
  • [17] Communicating with people with hearing loss: COVID-19 and beyond
    Maru, Devina
    Lewis, Jack Stancel-
    Easton, Graham
    Leverton, William E. J.
    BJGP OPEN, 2021, 5 (01) : 1 - 3
  • [18] Sudden irreversible hearing loss post COVID-19
    Koumpa, Foteini Stefania
    Forde, Cillian T.
    Manjaly, Joseph G.
    BMJ CASE REPORTS, 2020, 13 (11)
  • [19] Sudden Sensorineural Hearing Loss and COVID-19 Vaccination
    Briggs, Selena E.
    Brenner, Michael J.
    Chandrasekhar, Sujana S.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (02) : 196 - 197
  • [20] Covid-19: How effective are vaccines against the delta variant?
    Baraniuk, Chris
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374